Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,191,922
+$219,516 QoQ
Shares Held
28,318
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#1,325
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. JNJ ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,839 | $1,243,059 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,191,922 | 28,318 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $6,972,406 | 28,524 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $5,686,779 | 27,479 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,178,409 | 27,928 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,553,324 | 29,809 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,114,008 | 30,837 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,368,391 | 30,206 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,909,931 | 30,297 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,246,678 | 29,055 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $4,972,386 | 31,433 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,914,425 | 31,354 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,307,960 | 34,080 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,802,138 | 35,054 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,199,475 | 33,545 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,174,624 | 34,954 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,820,843 | 35,632 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,707,392 | 37,786 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,840,614 | 32,955 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,264,508 | 30,774 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,938,347 | 30,578 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,140,382 | 31,203 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,314,585 | 32,337 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,265,305 | 33,456 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,856,018 | 32,617 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,619,414 | 32,848 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,349,844 | 33,172 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||